Effect of levetiracetam on cardiac repolarization in healthy subjects: A single-dose, randomized, placebo- and active-controlled, four-way crossover study
- 29 February 2008
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 30 (2) , 260-270
- https://doi.org/10.1016/j.clinthera.2008.02.002
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Placebo-controlled study of levetiracetam in idiopathic generalized epilepsyNeurology, 2007
- Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsyNeurology, 2007
- Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizuresNeurology, 2006
- The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetamProceedings of the National Academy of Sciences, 2004
- Clinical Pharmacokinetics of LevetiracetamClinical Pharmacokinetics, 2004
- Pharmacokinetics and metabolism of 14 C-levetiracetam, a new antiepileptic agent, in healthy volunteersEuropean Journal of Clinical Pharmacology, 2003
- Focus on issues in measuring and interpreting changes in the QTc interval durationEuropean Heart Journal Supplements, 2001
- Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating MonotherapyEpilepsia, 2000
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Levetiracetam for partial seizuresNeurology, 2000